Valneva Se Adr Stock Equity Positions Weight
| VALN Stock | USD 3.99 0.36 8.28% |
Valneva SE ADR fundamentals help investors to digest information that contributes to Valneva SE's financial success or failures. It also enables traders to predict the movement of Valneva Stock. The fundamental analysis module provides a way to measure Valneva SE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Valneva SE stock.
Valneva | Equity Positions Weight |
Valneva SE ADR Company Equity Positions Weight Analysis
Valneva SE's Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
More About Equity Positions Weight | All Equity Analysis
Stock Percentage | = | % of Equities | in the fund |
Valneva Equity Positions Weight Driver Correlations
Understanding the fundamental principles of building solid financial models for Valneva SE is extremely important. It helps to project a fair market value of Valneva Stock properly, considering its historical fundamentals such as Equity Positions Weight. Since Valneva SE's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Valneva SE's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Valneva SE's interrelated accounts and indicators.
Click cells to compare fundamentals
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
| Competition |
According to the company disclosure, Valneva SE ADR has an Equity Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Valneva SE Current Valuation Drivers
We derive many important indicators used in calculating different scores of Valneva SE from analyzing Valneva SE's financial statements. These drivers represent accounts that assess Valneva SE's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Valneva SE's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 255.3M | 235.8M | 703.4M | 718.7M | 655.8M | 688.6M | |
| Enterprise Value | 235.8M | 256.6M | 604.4M | 581.7M | 738.6M | 775.5M |
Valneva SE ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Valneva SE's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Valneva SE's managers, analysts, and investors.Environmental | Governance | Social |
Valneva Fundamentals
| Return On Equity | -0.0396 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 375.04 M | ||||
| Shares Outstanding | 81.2 M | ||||
| Shares Owned By Institutions | 1.16 % | ||||
| Number Of Shares Shorted | 30.56 K | ||||
| Price To Book | 1.43 X | ||||
| Price To Sales | 2.11 X | ||||
| Revenue | 153.71 M | ||||
| Gross Profit | (68.06 M) | ||||
| EBITDA | (57.72 M) | ||||
| Net Income | (101.43 M) | ||||
| Cash And Equivalents | 336.22 M | ||||
| Cash Per Share | 5.74 X | ||||
| Total Debt | 208.82 M | ||||
| Debt To Equity | 1.43 % | ||||
| Current Ratio | 1.15 X | ||||
| Book Value Per Share | 1.55 X | ||||
| Cash Flow From Operations | (202.74 M) | ||||
| Short Ratio | 1.22 X | ||||
| Earnings Per Share | (0.13) X | ||||
| Target Price | 15.85 | ||||
| Number Of Employees | 676 | ||||
| Beta | 1.02 | ||||
| Market Capitalization | 335.14 M | ||||
| Total Asset | 460.06 M | ||||
| Retained Earnings | (561.2 M) | ||||
| Working Capital | 103.96 M | ||||
| Net Asset | 460.06 M |
About Valneva SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Valneva SE ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Valneva SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Valneva SE ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Valneva SE
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Valneva SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will appreciate offsetting losses from the drop in the long position's value.Moving together with Valneva Stock
Moving against Valneva Stock
| 0.94 | VCYT | Veracyte | PairCorr |
| 0.91 | VCEL | Vericel Corp Ord | PairCorr |
| 0.83 | DRTS | Alpha Tau Medical | PairCorr |
| 0.76 | DMAC | DiaMedica Therapeutics Upward Rally | PairCorr |
| 0.62 | DSGN | Design Therapeutics | PairCorr |
The ability to find closely correlated positions to Valneva SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Valneva SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Valneva SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Valneva SE ADR to buy it.
The correlation of Valneva SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Valneva SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Valneva SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Valneva SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Valneva SE Piotroski F Score and Valneva SE Altman Z Score analysis. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.13) | Revenue Per Share 2.3 | Quarterly Revenue Growth 0.204 | Return On Assets (0.11) | Return On Equity (0.04) |
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.